Delayed-type hypersensitivity against Semliki Forest virus in mice
- PMID: 422238
- PMCID: PMC414151
- DOI: 10.1128/iai.23.2.219-223.1979
Delayed-type hypersensitivity against Semliki Forest virus in mice
Abstract
After intracutaneous immunization with purified inactivated Semliki Forest virus, a delayed-type hypersensitivity without detectable antibodies in serum was obtained in BALB/c mice. Low doses of antigen given intraperitoneally induced antibodies. Intracutaneous immunization with much higher doses induced no specific antibodies, but a footpad swelling was observed after challenge with homolgous antigen. Pretreatment with cyclophosphamide before immunization enhanced footpad swelling. Microscopic examination of footpads from sensitized mice at 24 h after challenge showed a mononuclear infiltrate. The delayed-type reaction could be transferred to syngenic mice with lymph node cells, but not with spleen cells or serum. The biphasic character of the delayed-type hypersensitivity is discussed.
Similar articles
-
Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report.Arch Virol. 1983;78(1-2):115-8. doi: 10.1007/BF01310865. Arch Virol. 1983. PMID: 6316872
-
Cellular immunity against Semliki Forest virus in mice.Infect Immun. 1979 Feb;23(2):213-8. doi: 10.1128/iai.23.2.213-218.1979. Infect Immun. 1979. PMID: 311341 Free PMC article.
-
Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice.Arch Virol. 1980;65(3-4):211-7. doi: 10.1007/BF01314537. Arch Virol. 1980. PMID: 7416968
-
Delayed type hypersensitivity against semliki forest virus in mice: local transfer of delayed type hypersensitivity with thioglycollate-induced peritoneal exudate cells.Int Arch Allergy Appl Immunol. 1984;73(4):342-6. doi: 10.1159/000233495. Int Arch Allergy Appl Immunol. 1984. PMID: 6698625
-
Unique immunomodulating properties of dimethyl dioctadecyl ammonium bromide (DDA) in experimental viral vaccines.Adv Exp Med Biol. 1996;397:115-25. doi: 10.1007/978-1-4899-1382-1_16. Adv Exp Med Biol. 1996. PMID: 8718590 Review. No abstract available.
Cited by
-
Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.J Clin Microbiol. 1986 Oct;24(4):665-8. doi: 10.1128/jcm.24.4.665-668.1986. J Clin Microbiol. 1986. PMID: 3533979 Free PMC article.
-
Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report.Arch Virol. 1983;78(1-2):115-8. doi: 10.1007/BF01310865. Arch Virol. 1983. PMID: 6316872
-
Detection of Semliki Forest virus in cell culture by use of an enzyme immunoassay with peroxidase-labeled monoclonal antibodies specific for glycoproteins E1 and E2.J Clin Microbiol. 1984 Sep;20(3):387-90. doi: 10.1128/jcm.20.3.387-390.1984. J Clin Microbiol. 1984. PMID: 6386855 Free PMC article.
-
Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.Arch Virol. 1986;91(1-2):83-92. doi: 10.1007/BF01316730. Arch Virol. 1986. PMID: 3489451
-
Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.J Virol. 1985 May;54(2):546-51. doi: 10.1128/JVI.54.2.546-551.1985. J Virol. 1985. PMID: 2985817 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources